Status: Not yet recruiting
A Seamless, Adaptive Multiple-Ascending-Dose and Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations
A study of XTMAB-16 in patients with pulmonary sarcoidosis
Participants needed: 182
Trial details
Phase: Phase 1, Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Xentria, Inc.Updated: Jul 2, 2026
Eligibility criteria
Participant between 18 and 80 years (inclusive) of age. [+9]
Pregnant or breastfeeding women or women who are planning to become pregnant dur... [+29]